Novartis Investigative Site

Summary

Novartis Investigative Site is a medical facility located in Aurora, Colorado. This center is recognized for care of Multiple Sclerosis, Cancer, Chronic Obstructive Pulmonary Disease, Asthma, Heart Failure and other specialties. Novartis Investigative Site is involved with conducting 309 clinical trials across 296 conditions. There are 6 research doctors associated with this hospital, such as Marc Cornier, MD, Matthew M Heeney, Ranchhod Khant, and Karen Aspry.

Top PIs

Clinical Trials running at Novartis Investigative Site

Relapse

Motor and sensory neuropathy

Multiple Sclerosis

IgA Nephropathy

Proteinuria

Acute Kidney Injury

Atopic Dermatitis

Chronic Kidney Disease

Acute Glomerulonephritis

IgA Nephropathy or Immunoglobulin A Nephropathy

Remibrutinib vs Teriflunomide

for Multiple Sclerosis

This trial compares two medications, remibrutinib and teriflunomide, for treating patients with relapsing multiple sclerosis. These patients have repeated episodes of symptoms and need effective treatments. The medications work by controlling the immune system to prevent it from causing damage to the nervous system. Teriflunomide is an approved medication for adults with relapsing multiple sclerosis.

Recruiting

2 awards

Phase 3

Remibrutinib vs Teriflunomide

for Multiple Sclerosis

This trial compares remibrutinib and teriflunomide in patients with relapsing multiple sclerosis. It aims to find out which medication is more effective and safer. Both drugs work by controlling the immune system to reduce relapses. Teriflunomide is an approved treatment for adults with this condition.

Recruiting

2 awards

Phase 3